DelveInsight’s “Post-Surgical Pain Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Post-Surgical Pain, historical and forecasted epidemiology as well as the Post-Surgical Pain market trends in the United States, EU4 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
To Know in detail about the Post-Surgical Pain market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Post-Surgical Pain Market Forecast
Some of the key facts of the Post-Surgical Pain Market Report:
- The Post-Surgical Pain market size is anticipated to grow with a significant CAGR during the study period (2019-2032)
- In the 7MM, there were 66,000,000 incident cases of post-surgical pain in 2021
- The US reported the most surgical procedures in 2021, totaling 50,300,000, while the EU5 countries accounted for 17,000,000. With 15,300,000 surgical procedures performed in 2021, Japan came in second among the other 7MM countries
- The US reported the largest incident case count of post-surgical discomfort among the 7MM, or 40,300,000 cases, in 2021
- Key Post-Surgical Pain Companies: Menarini Group, Guidotti Farma, AcelRx Pharmaceuticals, Trevena, Inc., Heron Therapeutics, Innocoll Pharmaceuticals, DURECT Corporation, Pacira Pharmaceuticals, Baudax Bio, Bausch & Lomb, Ocular Therapeutix, Kala Pharmaceuticals, Inc, Medical Developments International Ltd (MVP), Hyloris Pharmaceuticals, AFT Pharmaceuticals, Cara Therapeutics, Vivozon, Avenue Therapeutics, Arthritis Innovation Corporation, MedinCell, Unither Pharmaceuticals, Esteve Pharmaceuticals, Formosa Pharmaceuticals, Neumentum Pharmaceuticals, Acadia Pharmaceuticals Inc., Nevakar, Inc., Taiwan Liposome Company (TLC), Viatris Inc. (formerly known as Mylan Inc.), Teikoku Pharma USA, Inc., Novartis Pharmaceuticals, Oculis, PainReform LTD, Concentric Analgesics, Mati Therapeutics Inc., and others
- Key Post-Surgical Pain Therapies: Opirangerine (VVZ-149), PRF-110, NVK-009, TLC590, TPU-006, OCS-01, CA-008, and others
- The Post-Surgical Pain epidemiology based on severity-specific cases analyzed that, out of the total Post-surgical pain cases in the United States, ~44.5% were of the moderate category
- The Post-Surgical Pain market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Post-Surgical Pain pipeline products will significantly revolutionize the Post-Surgical Pain market dynamics.
Post-Surgical Pain Overview
Following surgical treatments, postoperative pain is an expected and brief increase in background pain. It is a kind of pain that normally lasts only a few days to months or pain that is caused by soft tissue damage, such as a paper cut or sprained ankle. Although the discomfort lasts only a short while, it progressively goes away as the damaged tissues recover. Based on the length, it is further divided into acute and chronic pain.
Get a Free sample for the Post-Surgical Pain Market Report
https://www.delveinsight.com/sample-request/post-surgical-pain-market
Post-Surgical Pain Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.
Post-Surgical Pain Epidemiology Segmentation:
The Post-Surgical Pain market report proffers epidemiological analysis for the study period 2019–2032 in the 7MM segmented into:
- Total Prevalence of Post-Surgical Pain
- Prevalent Cases of Post-Surgical Pain by severity
- Gender-specific Prevalence of Post-Surgical Pain
- Diagnosed Cases of Episodic and Chronic Post-Surgical Pain
Download the report to understand which factors are driving Post-Surgical Pain epidemiology trends @ Post-Surgical Pain Epidemiology Forecast
Post-Surgical Pain Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Post-Surgical Pain market or expected to get launched during the study period. The analysis covers Post-Surgical Pain market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Post-Surgical Pain Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
Post-Surgical Pain Therapies and Key Companies
- Opirangerine (VVZ-149): Vivozon Inc.
- PRF-110: PainReform LTD
- NVK-009: Nevakar, Inc.
- TLC590: Taiwan Liposome Company (TLC)
- TPU-006: Teikoku Pharma USA, Inc
- OCS-01: Oculis
- CA-008: Concentric Analgesics
Discover more about therapies set to grab major Post-Surgical Pain market share @ Post-Surgical Pain Treatment Market
Post-Surgical Pain Market Drivers
- Increased patient pool
- Multimodal therapeutic strategies
- Awareness of the disease
- Research and developmental strategies
Post-Surgical Pain Market Barriers
- Knowledge and approach towards pain management
- Age-specific treatment (lacks for pediatric and children)
- Ignorance of pain
Scope of the Post-Surgical Pain Market Report
- Study Period: 2019–2032
- Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
- Key Post-Surgical Pain Companies: Menarini Group, Guidotti Farma, AcelRx Pharmaceuticals, Trevena, Inc., Heron Therapeutics, Innocoll Pharmaceuticals, DURECT Corporation, Pacira Pharmaceuticals, Baudax Bio, Bausch & Lomb, Ocular Therapeutix, Kala Pharmaceuticals, Inc, Medical Developments International Ltd (MVP), Hyloris Pharmaceuticals, AFT Pharmaceuticals, Cara Therapeutics, Vivozon, Avenue Therapeutics, Arthritis Innovation Corporation, MedinCell, Unither Pharmaceuticals, Esteve Pharmaceuticals, Formosa Pharmaceuticals, Neumentum Pharmaceuticals, Acadia Pharmaceuticals Inc., Nevakar, Inc., Taiwan Liposome Company (TLC), Viatris Inc. (formerly known as Mylan Inc.), Teikoku Pharma USA, Inc., Novartis Pharmaceuticals, Oculis, PainReform LTD, Concentric Analgesics, Mati Therapeutics Inc., and others
- Key Post-Surgical Pain Therapies: Opirangerine (VVZ-149), PRF-110, NVK-009, TLC590, TPU-006, OCS-01, CA-008, and others
- Post-Surgical Pain Therapeutic Assessment: Post-Surgical Pain current marketed and Post-Surgical Pain emerging therapies
- Post-Surgical Pain Market Dynamics: Post-Surgical Pain market drivers and Post-Surgical Pain market barriers
- Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies
- Post-Surgical Pain Unmet Needs, KOL’s views, Analyst’s views, Post-Surgical Pain Market Access and Reimbursement
To know more about Post-Surgical Pain companies working in the treatment market, visit @ Post-Surgical Pain Clinical Trials and Therapeutic Assessment
Table of Contents
1. Post-Surgical Pain Market Report Introduction
2. Executive Summary for Post-Surgical Pain
3. SWOT analysis of Post-Surgical Pain
4. Post-Surgical Pain Patient Share (%) Overview at a Glance
5. Post-Surgical Pain Market Overview at a Glance
6. Post-Surgical Pain Disease Background and Overview
7. Post-Surgical Pain Epidemiology and Patient Population
8. Country-Specific Patient Population of Post-Surgical Pain
9. Post-Surgical Pain Current Treatment and Medical Practices
10. Post-Surgical Pain Unmet Needs
11. Post-Surgical Pain Emerging Therapies
12. Post-Surgical Pain Market Outlook
13. Country-Wise Post-Surgical Pain Market Analysis (2019–2032)
14. Post-Surgical Pain Market Access and Reimbursement of Therapies
15. Post-Surgical Pain Market Drivers
16. Post-Surgical Pain Market Barriers
17. Post-Surgical Pain Appendix
18. Post-Surgical Pain Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
About DelveInsight
DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.
Media Contact
Company Name: DelveInsight Business Research
Contact Person: Gaurav Bora
Email:Send Email
Phone: 8774225362
Address:27 Drydock Ave S. Jones Blvd #2432
City: Boston
State: MA
Country: United States
Website: https://www.delveinsight.com/consulting/asset-prioritizaton-services
